Orum Therapeutics Conference Call: Pipeline Strategy and Next Steps

Written By Allen (Biho) Seo

Orum Therapeutics will hold a conference call to provide an update on its pipeline strategy, including the discontinuation of the ORM-6151 Phase 1 study, plans to advance its IND-cleared ORM-1153 program into a first-in-human Phase 1 trial, and priorities for the broader pipeline.


Event Details
Date: September 23, 2026
Time: 10:00 AM KST

*The Conference Call has ended. You can watch the video by clicking “View Conference Call Replay” below. Webcast : View Conference Call Replay
Presentation : View Presentation

Allen (Biho) Seo
Previous

2026 Extraordinary General Meeting
Next

Orum Therapeutics to Participate in NDR Hosted by Mirae Asset